FDA approves Pfizer's leukemia drug

(Reuters) - The U.S. Food and Drug Administration (FDA) on Friday approved Pfizer Inc's drug, Mylotarg, for certain patients with acute myeloid leukemia (AML).

FDA approves Pfizer's leukemia drug
Read More


Bagikan Berita Ini